These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12488806)

  • 21. Methamphetamine dependence with and without psychotic symptoms: A multi-modal brain imaging study.
    Vuletic D; Dupont P; Robertson F; Warwick J; Zeevaart JR; Stein DJ
    Neuroimage Clin; 2018; 20():1157-1162. PubMed ID: 30380522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Behavioral changes and brain energy metabolism dysfunction in rats treated with methamphetamine or dextroamphetamine.
    Feier G; Valvassori SS; Lopes-Borges J; Varela RB; Bavaresco DV; Scaini G; Morais MO; Andersen ML; Streck EL; Quevedo J
    Neurosci Lett; 2012 Nov; 530(1):75-9. PubMed ID: 23022501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resting brain metabolic correlates of neuroticism and extraversion in young men.
    Kim SH; Hwang JH; Park HS; Kim SE
    Neuroreport; 2008 May; 19(8):883-6. PubMed ID: 18463506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship of Alexithymia Ratings to Dopamine D2-type Receptors in Anterior Cingulate and Insula of Healthy Control Subjects but Not Methamphetamine-Dependent Individuals.
    Okita K; Ghahremani DG; Payer DE; Robertson CL; Mandelkern MA; London ED
    Int J Neuropsychopharmacol; 2016 May; 19(5):. PubMed ID: 26657175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amygdala-prefrontal disconnection in borderline personality disorder.
    New AS; Hazlett EA; Buchsbaum MS; Goodman M; Mitelman SA; Newmark R; Trisdorfer R; Haznedar MM; Koenigsberg HW; Flory J; Siever LJ
    Neuropsychopharmacology; 2007 Jul; 32(7):1629-40. PubMed ID: 17203018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response of cortical metabolic deficits to serotonergic challenge in familial mood disorders.
    Kegeles LS; Malone KM; Slifstein M; Ellis SP; Xanthopoulos E; Keilp JG; Campbell C; Oquendo M; Van Heertum RL; Mann JJ
    Am J Psychiatry; 2003 Jan; 160(1):76-82. PubMed ID: 12505804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers.
    Volkow ND; Chang L; Wang GJ; Fowler JS; Franceschi D; Sedler MJ; Gatley SJ; Hitzemann R; Ding YS; Wong C; Logan J
    Am J Psychiatry; 2001 Mar; 158(3):383-9. PubMed ID: 11229978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioral and functional neuroimaging evidence for prefrontal dysfunction in methamphetamine-dependent subjects.
    Paulus MP; Hozack NE; Zauscher BE; Frank L; Brown GG; Braff DL; Schuckit MA
    Neuropsychopharmacology; 2002 Jan; 26(1):53-63. PubMed ID: 11751032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic landscape of amphetamine and methamphetamine addiction in rodents.
    Godino A; Jayanthi S; Cadet JL
    Epigenetics; 2015; 10(7):574-80. PubMed ID: 26023847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users.
    McCann UD; Kuwabara H; Kumar A; Palermo M; Abbey R; Brasic J; Ye W; Alexander M; Dannals RF; Wong DF; Ricaurte GA
    Synapse; 2008 Feb; 62(2):91-100. PubMed ID: 17992686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterizing prefrontal cortical activity during inhibition task in methamphetamine-associated psychosis versus schizophrenia: a multi-channel near-infrared spectroscopy study.
    Okada N; Takahashi K; Nishimura Y; Koike S; Ishii-Takahashi A; Sakakibara E; Satomura Y; Kinoshita A; Takizawa R; Kawasaki S; Nakakita M; Ohtani T; Okazaki Y; Kasai K
    Addict Biol; 2016 Mar; 21(2):489-503. PubMed ID: 25619621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Midbrain functional connectivity and ventral striatal dopamine D2-type receptors: link to impulsivity in methamphetamine users.
    Kohno M; Okita K; Morales AM; Robertson CL; Dean AC; Ghahremani DG; Sabb FW; Rawson RA; Mandelkern MA; Bilder RM; London ED
    Mol Psychiatry; 2016 Nov; 21(11):1554-1560. PubMed ID: 26830141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A preliminary study: novelty seeking, frontal executive function, and dopamine receptor (D2) TaqI A gene polymorphism in patients with methamphetamine dependence.
    Han DH; Yoon SJ; Sung YH; Lee YS; Kee BS; Lyoo IK; Renshaw PF; Cho SC
    Compr Psychiatry; 2008; 49(4):387-92. PubMed ID: 18555060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gender difference in relationship between anxiety-related personality traits and cerebral brain glucose metabolism.
    Hakamata Y; Iwase M; Iwata H; Kobayashi T; Tamaki T; Nishio M; Matsuda H; Ozaki N; Inada T
    Psychiatry Res; 2009 Sep; 173(3):206-11. PubMed ID: 19682867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regional brain cerebral glucose metabolism and temperament: a positron emission tomography study.
    Hakamata Y; Iwase M; Iwata H; Kobayashi T; Tamaki T; Nishio M; Kawahara K; Matsuda H; Ozaki N; Honjo S; Inada T
    Neurosci Lett; 2006 Mar; 396(1):33-7. PubMed ID: 16356648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age-associated changes of cerebral glucose metabolic activity in both male and female deaf children: parametric analysis using objective volume of interest and voxel-based mapping.
    Kang E; Lee DS; Kang H; Lee JS; Oh SH; Lee MC; Kim CS
    Neuroimage; 2004 Aug; 22(4):1543-53. PubMed ID: 15275911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-frequency repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex restores attention bias to negative information in methamphetamine addicts.
    Zhang L; Cao X; Liang Q; Li X; Yang J; Yuan J
    Psychiatry Res; 2018 Jul; 265():151-160. PubMed ID: 29709789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prefrontal grey-matter changes in short-term and long-term abstinent methamphetamine abusers.
    Kim SJ; Lyoo IK; Hwang J; Chung A; Hoon Sung Y; Kim J; Kwon DH; Chang KH; Renshaw PF
    Int J Neuropsychopharmacol; 2006 Apr; 9(2):221-8. PubMed ID: 15982446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebral glucose metabolism abnormalities in patients with major depressive symptoms in pre-dialytic chronic kidney disease: statistical parametric mapping analysis of F-18-FDG PET, a preliminary study.
    Song SH; Kim IJ; Kim SJ; Kwak IS; Kim YK
    Psychiatry Clin Neurosci; 2008 Oct; 62(5):554-61. PubMed ID: 18950375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonmuscle myosin IIB as a therapeutic target for the prevention of relapse to methamphetamine use.
    Young EJ; Blouin AM; Briggs SB; Sillivan SE; Lin L; Cameron MD; Rumbaugh G; Miller CA
    Mol Psychiatry; 2016 May; 21(5):615-23. PubMed ID: 26239291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.